Louahed; Jamila

Patent Applications and Registrations

Patent applications and USPTO patent grants for Louahed; Jamila.The latest application filed is for "method of treating cancer with megea3 immunotherapeutic with braf inhibitor and/or mek inhibitor".

Company Profile

0.5.17

Louahed; Jamila - Rixensart BE
Louahed; Jamila - Brussels BE
Louahed; Jamila - Plymouth Meeting PA
Louahed; Jamila - Etterbeek BE
Louahed, Jamila - East Norristown PA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method Of Treating Cancer With MEGEA3 Immunotherapeutic With BRAF Inhibitor And/Or MEK Inhibitor App 20150147350 - Gerard; Catherine Marie Ghislaine ; et al.	2015-05-28
Fusion protein Grant 8,309,096 - Blais , et al. November 13, 2	2012-11-13
Isolated nucleic acid molecules which encode T cell inducible factors (TIFs), the proteins encoded, and uses thereof Grant 7,972,833 - Dumoutier , et al. July 5, 2	2011-07-05
Methods for the modulation of IL-13 Grant 7,919,248 - Zhou , et al. April 5, 2	2011-04-05
Method App 20110070268 - Brichard; Vincent ; et al.	2011-03-24
Method for Classifying Cancer Patients as Responder or Non-Responder to Immunotherapy App 20100247580 - Coche; Thierry ; et al.	2010-09-30
Fusion Protein App 20100029912 - Blais; Normand ; et al.	2010-02-04
Method For Identifying Whether A Patient Will Be Responder or Not to Immunotherapy App 20100021424 - Brichard; Vincent ; et al.	2010-01-28
Use of MAGE A3-Protein D Fusion Antigen in Immunotherapy Combined with Surgery, Chemotherapy or Radiotherapy for the Treatment of Cancer App 20100008980 - Brichard; Vincent ; et al.	2010-01-14
Methods for the Modulation of IL-13 App 20090191191 - Zhou; Yuhong ; et al.	2009-07-30
Asthma associated factors as targets for treating atopic allergies including asthma and related disorders App 20090068185 - Holroyd; Kenneth J. ; et al.	2009-03-12
Isolated nucleic acid molecules which encode T cell inducible factors (TIFs), the proteins encoded, and uses thereof App 20080213881 - Dumoutier; Laure ; et al.	2008-09-04
Antibodies against inducible TH2 cell factors App 20080096981 - Dong; Charles Qu ; et al.	2008-04-24
Methods for treating ICACC protein associated diseases Grant 7,211,254 - Holroyd , et al. May 1, 2	2007-05-01
Methods for the modulation of il-13 App 20040219149 - Zhou, Yuhong ; et al.	2004-11-04
Asthma associated factors as targets for treating atopic allergies including asthma and related disorders App 20040204578 - Holroyd, Kenneth J. ; et al.	2004-10-14
Isolated nucleic acid molecules which encode T cell inducible factors (TIFs), the proteins encoded, and uses thereof App 20040110189 - Dumoutier, Laure ; et al.	2004-06-10
Nucleic acids encoding a chloride channel protein Grant 6,716,603 - Holroyd , et al. April 6, 2	2004-04-06
Asthma associated factors as targets for treating atopic allergies including asthma and related disorders App 20030166150 - Renauld, Jean-Christophe ; et al.	2003-09-04
Asthma associated factors as targets for treating atopic allergies including asthma and related disorders App 20030078409 - Holroyd, Kenneth J. ; et al.	2003-04-24
Asthma associated factors as targets for treating atopic allergies including asthma and related disorders App 20020156013 - Renauld, Jean-Christophe ; et al.	2002-10-24
Isolated nucleic acid molecules which encode T cell inducible factors (TIFs), the proteins encoded, and used thereof App 20010024652 - Dumoutier, Laure ; et al.	2001-09-27

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.